Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TC-Reference-Cited by-同舟云学术

Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TC

Published:2020-06-20 Issue:8 Volume:99 Page:1855-1862
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Le Bourgeois Amandine^ORCID,Labopin Myriam,Marçais Ambroise,de Latour Regis Peffault,Blaise Didier,Chantepie Sylvain,N’Guyen Stéphanie,Maillard Natacha,Forcade Edouard,Yakoub-Agha Ibrahim,Huynh Anne,Marchand Tony,Bilger Karin,Ceballos Patrice,Charbonnier Amandine,Turlure Pascal,Rubio Marie-Thérese,Béné Marie Christine,Guillaume Thierry,Mohty Mohamad,Chevallier Patrice,

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-020-04074-7.pdf

Reference35 articles.

1. Chevallier P, Labopin M, Milpied N et al (2014) Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bone Marrow Transplant 49:361–365

2. Schmid C, Schleuning M, Ledderose G, Tischer J, Kolb HJ (2005) Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol 23:5675–5687

3. Schmid C, Schleuning M, Schwerdtfeger R et al (2006) Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation. Blood. 108(3):1092–1099

4. Krejci M, Doubek M, Dusek J, Brychtova Y, Racil Z, Navratil M, Tomiska M, Horky O, Pospisilova S, Mayer J (2013) Combination of fludarabine, amsacrine and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patient with high-risk acute myeloid leukemia. Ann Hematol 92(10):1397–1403

5. Ringdén O, Labopin M, Schmid C, Sadeghi B, Polge E, Tischer J, Ganser A, Michallet M, Kanz L, Schwerdtfeger R, Nagler A, Mohty M, the Acute Leukaemia Working Party of the EBMT (2017) Sequential chemotherapy followed by reduced-intensity conditioning and allogeneic haematopoiétic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukemia: a survey from the Acute Leukemia Working Party of EBMT. Br J Haematol 176(3):431–439

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic Stem Cell Transplantation in Refractory Acute Myeloid Leukaemia;Cells;2024-04-26

2. Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation;Bone Marrow Transplantation;2023-11-17

3. Non-Expressed Donor KIR3DL1 Alleles May Represent a Risk Factor for Relapse after T-Replete Haploidentical Hematopoietic Stem Cell Transplantation;Cancers;2023-05-13

4. Impact of disease burden on clinical outcomes of AML patients receiving allogeneic hematopoietic cell transplantation: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation;Bone Marrow Transplantation;2023-04-11

5. Validation of the Transplant Conditioning Intensity (TCI) Index for Allogeneic Hematopoietic Cell Transplantation;2023-03-24